Trials / Completed
CompletedNCT02022930
Hydros and Hydros-TA Joint Therapy for Pain Associated With Knee Osteoarthritis
A Multi-center, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Hydros and Hydros-TA Joint Therapies for Management of Pain Associated With Osteoarthritis in the Knee
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 510 (estimated)
- Sponsor
- Carbylan Therapeutics, Inc. · Industry
- Sex
- All
- Age
- 40 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and efficacy of Hydros-TA Joint Therapy for relief of pain due to OA of the knee. Hydros-TA is designed to provide fast acting and long lasting pain relief for up to six months with a single IA injection.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Hydros | |
| DEVICE | Hydros-TA | |
| DRUG | Triamcinolone Acetonide |
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2015-12-01
- Completion
- 2016-06-01
- First posted
- 2013-12-30
- Last updated
- 2016-08-25
Locations
5 sites across 3 countries: Australia, Canada, Netherlands Antilles
Source: ClinicalTrials.gov record NCT02022930. Inclusion in this directory is not an endorsement.